欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/2300/001
药品名称Bilaxten 20 mg Tabletten
活性成分
    • bilastine 20.0 mg
剂型Tablet
上市许可持有人Menarini International Operations Luxembourg S.A. 1, Avenue de la Gare 1611 Luxembourg Luxembourg
参考成员国 - 产品名称Germany (DE)
Bilaxten 20mg Tabletten
互认成员国 - 产品名称
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Nasitop 20 mg Tabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Clatra
    • Latvia (LV)
      Opexa 20 mg tabletes
    • Lithuania (LT)
      Opexa 20 mg tabletės
    • Estonia (EE)
    • Hungary (HU)
      LENDIN 20 mg tabletta
    • Bulgaria (BG)
      Fortecal
    • Cyprus (CY)
      BILAZ 20mg TABS
    • Czechia (CZ)
      Depocid 20 mg Tableta
    • Romania (RO)
      BORENAR 20 mg comprimate
    • Slovakia (SK)
      Bilahist 20 mg tablety
    • Slovenia (SI)
    • Malta (MT)
      Drynol 20mg tablets
许可日期2010/09/08
最近更新日期2024/10/25
药物ATC编码
    • R06AX29 bilastine
申请类型
  • TypeLevel1:New Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase